Jorunn E Eyfjord
Jorunn E Eyfjord
Faculty of Medicine, University of Iceland
Verified email at hi.is
Title
Cited by
Cited by
Year
Signatures of mutational processes in human cancer
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
66432013
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies
A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ...
The American Journal of Human Genetics 72 (5), 1117-1130, 2003
40452003
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ...
The American Journal of Human Genetics 62 (3), 676-689, 1998
36491998
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL
J Zha, H Harada, E Yang, J Jockel, SJ Korsmeyer
Cell 87 (4), 619-628, 1996
32311996
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
13412016
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ...
Nature genetics 12 (3), 333-337, 1996
10351996
A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes
S Thorlacius, G Olafsdottir, L Tryggvadottir, S Neuhausen, JG Jonasson, ...
Nature genetics 13 (1), 117-119, 1996
6061996
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
M Olivier, A Langer, P Carrieri, J Bergh, S Klaar, J Eyfjord, C Theillet, ...
Clinical cancer research 12 (4), 1157-1167, 2006
5352006
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
AC Antoniou, AP Cunningham, J Peto, DG Evans, F Lalloo, SA Narod, ...
British journal of cancer 98 (8), 1457-1466, 2008
5042008
HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ...
Nature medicine 23 (4), 517, 2017
4322017
Population-based study of risk of breast cancer in carriers of BRCA2 mutation
S Thorlacius, JP Struewing, P Hartage, GH Olafsdottir, H Sigvaldason, ...
The Lancet 352 (9137), 1337-1339, 1998
4291998
Study of a single BRCA2 mutation with high carrier frequency in a small population.
S Thorlacius, S Sigurdsson, H Bjarnadottir, G Olafsdottir, JG Jonasson, ...
American journal of human genetics 60 (5), 1079, 1997
3521997
Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.
IBC Group, IBC Group
Science 345 (345(6196):1251343), 2014
3052014
Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer
V Birgisdottir, OA Stefansson, SK Bodvarsdottir, H Hilmarsdottir, ...
Breast cancer research 8 (4), 1-10, 2006
2862006
Prostate cancer progression and survival in BRCA2 mutation carriers
L Tryggvadóttir, L Vidarsdóttir, T Thorgeirsson, JG Jonasson, ...
Journal of the National Cancer Institute 99 (12), 929-935, 2007
2352007
Screening for germ line TP53 mutations in breast cancer patients
AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ...
Cancer research 52 (11), 3234-3236, 1992
2301992
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study
EK Bancroft, EC Page, E Castro, H Lilja, A Vickers, D Sjoberg, M Assel, ...
European urology 66 (3), 489-499, 2014
2242014
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains
AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ...
Genes, Chromosomes and Cancer 14 (1), 71-75, 1995
2051995
DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity
BZ Yuan, X Zhou, ME Durkin, DB Zimonjic, K Gumundsdottir, JE Eyfjord, ...
Oncogene 22 (3), 445-450, 2003
1982003
The topography of mutational processes in breast cancer genomes
S Morganella, LB Alexandrov, D Glodzik, X Zou, H Davies, J Staaf, ...
Nature communications 7 (1), 1-11, 2016
1812016
The system can't perform the operation now. Try again later.
Articles 1–20